Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 2/20 | 0.35 |
| ▸ | CES1 | P23141 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31711755 | 0.97 | CA1 (0.36) | CA1CA2CA4CA12CA7 | |
| SCHEMBL31711754 | 0.97 | CA1 (0.36) | CA1CA2CA4CA12CA7 | |
| SCHEMBL12352227 | 0.97 | CA1 (0.36) | CA1CA2CA4CA12CA7 | |
| SCHEMBL31711743 | 0.97 | CA1 (0.36) | CA1CA2CA4CA12CA7 | |
| SCHEMBL31711742 | 0.96 | CA1 (0.39) | CA1CA2CA4CA12CA7 | |
| SCHEMBL1995798 | 0.93 | CA1 (0.41) | CA1CA2CA4CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL6003881 | 0.89 | CA1 (0.39) | CA1CA2CA4CA12CA7 | |
| SCHEMBL5086821 | 0.89 | CA1 (0.39) | CA1CA2CA4CA12CA7 | |
| SCHEMBL21201794 | 0.88 | NPC1 (0.33) | CA1CA2CA4CA12CA7 | |
| SCHEMBL2937298 | 0.88 | NPC1 (0.38) | CA1CA2CA4CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018279-A1 | Cyclic Containing Polymer Compositions Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Process for Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-01-18 | — | — | US | disclosed |
| US-20230348634-A1 | Propylene Polymers Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Homogeneous Process for Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230348640-A1 | Propylene Copolymers Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Homogeneous Process for Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230348642-A1 | Ethylene-Alpha-Olefin-Diene Monomer Copolymers Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Homogeneous Process for Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230312772-A1 | Multidentate Lewis Base Catalysts and Methods for use Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-05 | — | — | US | disclosed |
| US-11766669-B2 | Hexahydrocyclopenta[e]-as-indacen-1-yl and octahydrobenzo[e]-as-indacen-1-yl based catalyst complexes and process for use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-11738334-B2 | Supported catalyst systems and processes for use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-11739169-B2 | Solubility improvement of non-metallocene transition metal complexes in aliphatic hydrocarbon solvents | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-20230212330-A1 | Metallocene Catalysts for Producing Vinyl-Terminated Polyalphaolefins and Methods Associated Therewith | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-07-06 | — | — | US | disclosed |
| US-11661465-B2 | Dimer selective metallocene catalysts, non-aromatic hydrocarbon soluble activators, and processes to produce poly alpha-olefin oligmers therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-05-30 | — | — | US | disclosed |
| WO-2011000939-A1 | USE OF SUBSTITUTED PERIFLANTHENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2011-01-06 | — | — | WO | disclosed |
| WO-2010097433-A1 | QUINONE COMPOUNDS AS DOPANTS IN ORGANIC ELECTRONICS | BASF SE (DE) | 2010-09-02 | — | — | WO | disclosed |
| EP-2181172-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2010-05-05 | — | — | EP | disclosed |
| WO-2009147237-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2009-12-10 | — | — | WO | disclosed |
| US-20090301552-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2009-12-10 | — | — | US | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| WO-2009024512-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2009-02-26 | — | — | WO | disclosed |
| WO-2009000831-A1 | BROMINE-SUBSTITUTED RYLENE TETRACARBOXYLIC ACID DERIVATIVES, AND THE USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | WO | disclosed |
| US-6129863-A | Clean generation of a perfluoroaryl grignard reagent | ALBEMARLE CORPORATION (US) | 2000-10-10 | — | — | US | disclosed |
| WO-2000035923-A1 | CLEAN GENERATION OF A PERFLUOROARYL GRIGNARD REAGENT | ALBEMARLE CORPORATION (US) | 2000-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090301552-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO4C1, SLCO2B1 | CA1 520/4885CA2 328/4885CA4 343/4885 |
| US-11766669-B2 | Hexahydrocyclopenta[e]-as-indacen-1-yl and octahydrobenzo[e]-as-indacen-1-yl based catalyst complexes and process for use thereof | MLX, ZYX, TXN | CA1 4054/4885CA2 3255/4885CA4 4465/4885 |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | FXR2, FXR1, FTO | CA1 143/4885CA2 1294/4885CA4 347/4885 |
| US-11661465-B2 | Dimer selective metallocene catalysts, non-aromatic hydrocarbon soluble activators, and processes to produce poly alpha-olefin oligmers therewith | NONO, TPR, ZNF787 | CA1 2086/4885CA2 3246/4885CA4 2616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.